The prognostic value of glomerular immaturity in the nephrotic syndrome in children

Danuta Ostalska-Nowicka1, Jacek Zachwieja, Janusz Maciejewski

  • 1Department of Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences, ul. Szpitalna 27/33, 60-572 Poznan, Poland. dostalska@interia.pl

Insights

Glomerular immaturity in children with nephrotic syndrome indicates a poorer prognosis. This finding highlights the need for tailored treatment strategies in pediatric nephrotic syndrome cases with these specific histological signs.

Area of Science:

  • Pediatric Nephrology
  • Renal Pathology
  • Childhood Kidney Disease

Background:

  • Nephrotic syndrome is a significant kidney disorder in children.
  • Histological examination, specifically renal biopsy, is crucial for diagnosis.
  • Diffuse mesangial proliferation is a common finding in pediatric nephrotic syndrome.

Purpose of the Study:

  • To investigate the clinical course of nephrotic syndrome in children.
  • To compare outcomes between children with and without signs of glomerular immaturity.
  • To analyze the impact of glomerular immaturity on treatment response and disease progression.

Main Methods:

  • Retrospective analysis of pediatric patients with a first episode of nephrotic syndrome.
  • Inclusion of a study group with diffuse mesangial proliferation and glomerular immaturity signs.
  • Comparison with a control group exhibiting diffuse mesangial proliferation without immaturity signs.

Main Results:

  • Children with glomerular immaturity showed a higher frequency of steroid resistance (P=0.0234).
  • Younger children (<1 year) and those with low initial serum albumin (<1.0 g/dl) had a less favorable clinical course.
  • Glomerular immaturity was associated with unfavorable disease course and treatment challenges.

Conclusions:

  • Signs of glomerular immaturity in pediatric nephrotic syndrome are linked to adverse clinical outcomes.
  • Early identification of glomerular immaturity may guide more aggressive or tailored therapeutic approaches.
  • Further research is warranted to optimize management strategies for children with these specific renal histological findings.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...